Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
OSF St. Francis Medical Center
mi
from
Peoria, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
OSF St. Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Peru
mi
from
Peru, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Peru
mi
from
Peru, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois Valley Community Hospital
mi
from
Peru, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois Valley Community Hospital
mi
from
Peru, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Princeton
mi
from
Princeton, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Princeton
mi
from
Princeton, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Perry Memorial Hospital
mi
from
Princeton, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Perry Memorial Hospital
mi
from
Princeton, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Spring Valley
mi
from
Spring Valley, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Spring Valley
mi
from
Spring Valley, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Michiana Hematology-Oncology
mi
from
Elkhart, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Michiana Hematology-Oncology
mi
from
Elkhart, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Elkhart General Hospital
mi
from
Elkhart, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Elkhart General Hospital
mi
from
Elkhart, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Howard Community Hospital
mi
from
Kokomo, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Howard Community Hospital
mi
from
Kokomo, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Center for Cancer Therapy at LaPorte Hospital and Health Services
mi
from
La Porte, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Center for Cancer Therapy at LaPorte Hospital and Health Services
mi
from
La Porte, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Saint Anthony Memorial Health Centers
mi
from
Michigan City, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Saint Anthony Memorial Health Centers
mi
from
Michigan City, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Michiana Hematology-Oncology, PC - South Bend
mi
from
Mishawaka, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Michiana Hematology-Oncology, PC - South Bend
mi
from
Mishawaka, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Saint Joseph Regional Medical Center
mi
from
Mishawaka, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Saint Joseph Regional Medical Center
mi
from
Mishawaka, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Michiana Hematology Oncology
mi
from
Plymouth, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Michiana Hematology Oncology
mi
from
Plymouth, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Reid Hospital & Health Care Services
mi
from
Richmond, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Reid Hospital & Health Care Services
mi
from
Richmond, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
CCOP - Northern Indiana CR Consortium
mi
from
South Bend, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
CCOP - Northern Indiana CR Consortium
mi
from
South Bend, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Memorial Hospital of South Bend
mi
from
South Bend, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
South Bend Clinic
mi
from
South Bend, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
South Bend Clinic
mi
from
South Bend, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Michiana Hematology Oncology PC - La Porte
mi
from
Westville, IN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Michiana Hematology Oncology PC - La Porte
mi
from
Westville, IN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
McFarland Clinic, PC
mi
from
Ames, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Bettendorf, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Medical Oncology and Hematology Associates-West Des Moines
mi
from
Clive, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Medical Oncology and Hematology Associates-West Des Moines
mi
from
Clive, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
mi
from
Des Moines, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Medical Oncology and Hematology Associates at Mercy Cancer Center
mi
from
Des Moines, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Medical Oncology and Hematology Associates at Mercy Cancer Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
John Stoddard Cancer Center at Iowa Lutheran Hospital
mi
from
Des Moines, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
John Stoddard Cancer Center at Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas - Fort Scott
mi
from
Fort Scott, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas - Fort Scott
mi
from
Fort Scott, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas-Independence
mi
from
Independence, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas-Independence
mi
from
Independence, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Liberal
mi
from
Liberal, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Liberal
mi
from
Liberal, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Medical Arts Tower
mi
from
Wichita, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Medical Arts Tower
mi
from
Wichita, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
CCOP - Wichita
mi
from
Wichita, KA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials